"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies

Go back to "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) Delayed: 13.47 +0.02 (0.15%)
Previous Close $13.45    52 Week High $19.40 
Open $13.48    52 Week Low $12.50 
Day High $13.56    P/E N/A 
Day Low $13.45    EPS $0.00 
Volume 380,312       

(NASDAQ: GTBP) Delayed: 0.49 -0.02 (3.92%)
Previous Close $0.51    52 Week High
Open $0.54    52 Week Low
Day High $0.56    P/E N/A 
Day Low $0.48    EPS
Volume 2,977,492       

Oncolytics Biotech, Inc. (NASDAQ: ONCY) Delayed: 0.92 -0.04 (4.17%)
Previous Close $0.96    52 Week High $1.37 
Open $0.99    52 Week Low $0.24 
Day High $1.02    P/E N/A 
Day Low $0.91    EPS $0.00 
Volume 1,036,335       

(NASDAQ: SNSE) Delayed: 13.85 --0 (-0%)
Previous Close $13.85    52 Week High
Open $13.85    52 Week Low
Day High $13.85    P/E N/A 
Day Low $13.85    EPS
Volume 3,762,082       

(NASDAQ: VIR) Delayed: 9.57 +0.41 (4.48%)
Previous Close $9.16    52 Week High
Open $9.29    52 Week Low
Day High $9.63    P/E N/A 
Day Low $9.16    EPS
Volume 1,793,539